As we live through an unprecedented global public health crisis, our priority is two-fold: to protect the health and safety of our employees and to deliver on our mission supporting our government sponsors and partners.
Six Steps to a Safe, Trusted Election
There is one thing every American voter can agree upon—we all want our vote to count. The challenges before the COVID-19 pandemic were already tough enough. Now, the most fundamental aspect of our democracy—the ability to gather together to choose our leaders—is at heightened risk because of fear of spreading the disease.
Read the White Paper Planning for On-Campus K-12 Education During COVID-19
As K-12 leaders decide about bringing students back to campus, decisions should be data-driven. The Coalition's new white paper outlines key strategies and criteria to help leaders make data-informed decisions about opening schools safely. Recommendations include not opening unless new cases are below 1 per 100,000 residents per day and focusing on at-risk populations.
Read the White Paper The Fight Is In Us
MITRE proudly serves as an integral contributor to “The Fight Is In Us,” a national coalition that lets COVID-19 survivors become heroes by donating blood plasma. Filled with antibodies that can take down the coronavirus, the plasma is used to treat COVID-19 patients and to fuel research into other medicines.
Donate Plasma COVID-19 Healthcare Coalition Impact Report
MITRE is proud to coordinate the work of the COVID-19 Healthcare Coalition, a public-interest, private-sector response to the pandemic. Since mid-March, the Coalition has created resources and tools that are impacting the COVID fight. The July 2020 Members Report highlights key Coalition actions and achievements.
Read the Report
A Letter from MITRE’s President and CEO Jason Providakes
On this page you will find the insights, impact, and actions MITRE is taking to protect the health and well-being of our workforce, our communities, and the nation.
As a company chartered to work in the public interest, we are fully mobilized to deliver on our mission during this unprecedented global public health crisis.
We are guided by three responsibilities: to protect the health and well-being of our employees, deliver on our mission in support of our government sponsors, and lead with coalition members in response to the pandemic crisis. We are fully maintaining operations with over 7,000 employees working remotely, and in doing so, will continue mission-essential work for the federal government, including key public health agencies, Department of Homeland Security, the FAA, and the Department of Defense.
Whether in times of crisis or calm, MITRE's health experts have one goal: to accelerate health innovation.
CEO Update: Making an Impact on Solving Our World's Toughest Problems
President and CEO Jason Providakes shares how our people have responded to COVID-19 and how we are sparking innovation with the new MITRE Labs.
Read the article on LinkedIn Focal Point: COVID-19
As the coronavirus spread globally, it launched the world into widespread turmoil. Armed with our record of trusted collaboration and objective insight, MITRE joined the fight against COVID-19.
Read this collection of stories CEO Update: MITRE Prepares For Onsite Re-Entry
In a letter to employees on May 6, 2020, our President and CEO Jason Providakes outlined how MITRE is preparing for onsite re-entry and the data-driven criteria that must be met before easing existing onsite office restrictions.
Read the letter on LinkedIn Stronger Action Required to Stop COVID-19
Americans must reduce social contact by 90 percent to effectively stop the COVID-19 pandemic. Immediately closing all schools and learning institutions nationwide is one of 14 actions identified by MITRE's infectious disease analytics team that can help stop the spread of COVID-19.
Read the White Paper Preserving the Healthcare Delivery System is Essential to Protect the Population Against the Spread of COVID-19
The mission of the COVID-19 Healthcare Coalition, a collaborative industry response to the novel coronavirus is to help save lives by providing real-time insights to aid healthcare delivery and help protect U.S. populations. MITRE is coordinating the private sector response and serving as an independent party to facilitate communication, aggregate de-identified data – from clinical insights to resource requirements like beds and ventilators – and coordinate the response across a range of organizations.
Visit the Site Empowering Individuals to Report Symptoms Facilitates Public Health
Sara Alert™ is a standards-based, open source tool developed by MITRE in partnership with national public health organizations to track individuals at risk or with symptoms of COVID-19. The tool, in trial now, provides public health departments real-time insights. Sara Alert offers multiple access methods including web, text, email, and phone calls. The tool is being developed to be disease-independent, so it can be refined to support any future diseases. Watch this interview with Dr. Paul Jarris, chief medical advisor for MITRE’s health transformation center. Tracking COVID-19 through Data and Public-Private Collaboration
The novel coronavirus is fast and aggressive. But so are the many organizations—public and private—that are bring their resources to the fight, including MITRE.
Read the Story Crowdsourcing Innovation Through MITRE's COVID-19 Idea Challenge
There’s no greater challenge facing our nation than the COVID-19 crisis. So we’re encouraging MITRE’s 8,000-plus employee base to contribute ideas to address the pandemic. Through the COVID-19 Idea Challenge, MITRE is funding research and development of selected ideas, giving high priority to solutions we can deploy immediately and scale quickly. By crowdsourcing innovation across our organization, we can tap into the full potential of the best problem-solvers in the world.
Federal Contract Vehicles and Initiatives
MITRE's Acquisition in the Digital Age (AiDA) provides up-to-date information regarding federal authorities, contractual vehicles, and initiatives available to support the COVID-19 response.